Informe sobre estado del mercado y patentes de medicamentos para VIH-TB-VHC

Informe sobre estado del mercado y patentes de medicamentos para VIH-TB-VHC

Los presentes documentos incluye información relevante, acerca del análisis de mercado del estado de las patentes y registros sanitarios para los medicamentos del Virus de Inmunodeficiencia Humana -VIH-, medicamentos para la Tuberculosis -TB- y medicamentos para el Virus de la Hepatitis C -VHC-, para el año 2019.

El análisis se realizó para los países de Guatemala, El Salvador y Honduras, por medio de una revisión del gasto en salud con fondos públicos para estos medicamentos.

 

 

4 Comentarios
  • google

    19 abril, 2021a12:45 am Responder

    Hi there to every body, it’s my first pay
    a quick visit of this webpage; this webpage contains remarkable and
    actually fine data in favor of visitors.

    Also visit my web page :: google

  • delta 8 THC for sale area 52

    26 abril, 2021a5:52 am Responder

    Just wish to say your article is as astonishing.
    The clarity in your post is just spectacular and i could assume you’re an expert on this subject.
    Fine with your permission allow me to grab your feed to keep updated with forthcoming post.
    Thanks a million and please carry on the enjoyable work.

    delta 8 THC for sale area 52 – delta 8 THC for sale area 52

    delta 8 THC for sale area 52 – delta 8 carts Area 52

    delta 8 THC area 52 – delta 8 carts Area 52

    delta 8 THC for sale area 52 – Area 52 Delta 8 THC

    buy delta 8 THC area 52 – Area 52 delta 8 carts

  • buy cialis online cheap

    17 julio, 2021a4:59 pm Responder

    I’m more than happy to discover this website. I wanted to thank you for ones time for this
    particularly wonderful read!! I definitely liked every bit of it and i also have you book-marked to see new stuff in your blog.

    • ITPC LATCA

      19 julio, 2021a6:48 pm Responder

      Thank you for the wishes, we glad you like our site and we hope you help us to share our content anytime you can in your RRSS.

Publicar un comentario